The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Combination trastuzumab and chemotherapy to induce immunity to multiple tumor antigens in patients with HER2-positive metastatic breast cancer: NCCTG (Alliance) studies N0337 and N98-32-52.
Raphael Clynes
No relevant relationships to disclose
Keith L. Knutson
No relevant relationships to disclose
Karla V. Ballman
No relevant relationships to disclose
Courtney L. Erskine
No relevant relationships to disclose
Nadine Norton
No relevant relationships to disclose
Susan V. Sumrall
No relevant relationships to disclose
Donald W. Northfelt
No relevant relationships to disclose
Winston Tan
No relevant relationships to disclose
Carmen Julia Calfa
No relevant relationships to disclose
Mark D. Pegram
No relevant relationships to disclose
Edith A. Perez
No relevant relationships to disclose